(2R,11R)-6,11-diethyl-3-(furan-3-ylmethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol

(1R,9R,13R)-1,13-Diethyl-10-(3-furylmethyl)-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol

(1R,9R,13R)-1,13-Diethyl-10-(3-furylmethyl)-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol

(1R,9R,13R)-1,13-Diéthyl-10-(3-furylméthyl)-10-azatricyclo[7.3.1.0~2,7~]tridéca-2,4,6-trién-4-ol

(2R,11R)-6,11-diethyl-3-(furan-3-ylmethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol

2,6-Methano-3-benzazocin-8-ol, 6,11-diethyl-3-(3-furanylmethyl)-1,2,3,4,5,6-hexahydro-, (2R,6R,11R)-

(1S,9R,13R)-1,13-diethyl-10-(furan-3-ylmethyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol

(−)-2-(3-Furylmethyl)-5,9-diethyl-2'

(−)-2-(3-Furylmethyl)-5,9-diethyl-2′-hydroxy-6,7-benzomorphan

(−)-Mr 2266

2,6-Methano-3-benzazocin-8-ol, 6,11-diethyl-3-(3-furanylmethyl)-1,2,3,4,5,6-hexahydro-, (2R-(2α,6α,11R*))-

56649-76-4

6,11-Diethyl-3-furan-3-ylmethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol

MR-2266-BS

MRZ 2266 BS

OPRD_HUMAN

OPRK_HUMAN

OPRM_HUMAN

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor